Select Language:
Neuralink, the brain implant company founded by Elon Musk, has successfully implanted its devices in 12 paralyzed patients. These individuals can now operate digital and physical tools purely through their thoughts. In June, the company raised $650 million to support further development. Musk announced on X that Neuralink plans to begin high-volume manufacturing of its brain-computer interfaces in 2026 and will transition to fully automated surgical procedures for implanting the devices.
The company initiated human trials in 2024 after overcoming initial safety concerns from the U.S. Food and Drug Administration, which had initially rejected their application in 2022. A recent illustration shows a smartphone bearing the Neuralink logo resting on a computer motherboard, emphasizing the company’s focus on integrating advanced technology with neural functions.
In September, Neuralink reported that its implants are being used by 12 individuals worldwide with severe paralysis, enabling them to control devices and tools through thought. The firm’s push towards large-scale production aims to make neural interfaces more accessible and practical for broader use.
